Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

9.320 +0.420 (+4.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,342,506
Open 8.930
Bid (Size) 8.100 (1)
Ask (Size) 9.900 (2)
Prev. Close 8.900
Today's Range 8.800 - 9.420
52wk Range 8.050 - 19.11
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025
From NeoGenomics, Inc.
Via Business Wire
Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting... 
Via StockStory

Performance

YTD
-43.5%
-43.5%
1 Month
-8.9%
-8.9%
3 Month
-36.9%
-36.9%
6 Month
-31.1%
-31.1%
1 Year
-35.8%
-35.8%

More News

Read More
NeoGenomics Completes Acquisition of Pathline
From NeoGenomics, Inc.
Via Business Wire
Demystifying NeoGenomics: Insights From 6 Analyst Reviews
Via Benzinga
5 Analysts Assess NeoGenomics: What You Need To Know
Via Benzinga
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Via StockStory
Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics
From NeoGenomics, Inc.
Via Business Wire
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Via StockStory
Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses
Via StockStory
3 Reasons to Sell NEO and 1 Stock to Buy Instead
Via StockStory
NeoGenomics Appoints Warren Stone as President & Chief Operating Officer
From NeoGenomics, Inc.
Via Business Wire
Earnings Scheduled For March 18, 2025
Via Benzinga
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
Via StockStory
3 Small-Cap Stocks in Hot Water
Via StockStory
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
From NeoGenomics, Inc.
Via Business Wire
3 Healthcare Stocks Skating on Thin Ice
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
What To Expect From RadNet’s (RDNT) Q4 Earnings
Via StockStory
NeoGenomics to Participate in Upcoming Investor Conferences
From NeoGenomics, Inc.
Via Business Wire
Why NeoGenomics (NEO) Shares Are Trading Lower Today
Via StockStory
NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets
Via StockStory
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
From NeoGenomics, Inc.
Via Business Wire
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Earnings Scheduled For February 18, 2025
Via Benzinga

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 9.320
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 04/11/25 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.14B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.